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Abstract
Background
Treatment effects of removable functional appliances in Class II malocclusion patients
according to the pre-pubertal or pubertal growth phase has yet to be clarified.
Objectives
To assess and compare skeletal and dentoalveolar effects of removable functional appli-
ances in Class II malocclusion treatment between pre-pubertal and pubertal patients.
Search methods
Literature survey using the Medline, SCOPUS, LILACS and SciELO databases, the
Cochrane Library from inception to May 31, 2015. A manual search was also performed.
Selection criteria
Randomised (RCTs) or controlled clinical trials with a matched untreated control group. No
restrictions were set regarding the type of removable appliance whenever used alone.
Data collection and analysis
For the meta-analysis, cephalometric parameters on the supplementary mandibular growth
were the main outcomes, with other cephalometric parameters considered as secondary
outcomes. Risk of bias in individual and across studies were evaluated along with sensitivity
analysis for low quality studies. Mean differences and 95% confidence intervals for annual-
ised changes were computed according to a randommodel. Differences between pre-
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pubertal and pubertal patients were assessed by subgroup analyses. GRADE assessment
was performed for the main outcomes.
Results
Twelve articles (but only 3 RCTs) were included accounting for 8 pre-pubertal and 7 puber-
tal groups. Overall supplementary total mandibular length and mandibular ramus height
were 0.95 mm (0.38, 1.51) and 0.00 mm (-0.52, 0.53) for pre-pubertal patients and 2.91 mm
(2.04, 3.79) and 2.18 mm (1.51, 2.86) for pubertal patients, respectively. The subgroup dif-
ference was significant for both parameters (p<0.001). No maxillary growth restrain or
increase in facial divergence was seen in either subgroup. The GRADE assessment was
low for the pre-pubertal patients, and generally moderate for the pubertal patients.
Conclusions
Taking into account the limited quality and heterogeneity of the included studies, functional
treatment by removable appliances may be effective in treating Class II malocclusion with
clinically relevant skeletal effects if performed during the pubertal growth phase.
Introduction
The mandibular condyles, including their cartilage, have a primary role in the development
and growth of the oro-facial complex. In this regard, a deficient growth of the condyles may
results in mandibular retrognathia, also referred as skeletal Class II malocclusion. Interestingly,
animal studies have shown that forward mandibular displacement enhances condylar growth
resulting in significant changes in the morphology of the Mandible [1], [2]. Such induced con-
dylar growth has been shown to be characterized by a thickness of the condrogenic, prolifer-
ative, and hypertrophic layers of condylar cartilage on the posterior aspect of the condyle, thus
yielding to an increase in total mandibular length [1], [2].
According to this biological evidence, an orthopaedic approach to treat skeletal Class II mal-
occlusion in growing subjects is based on forward positioning of the mandible [3]. For this pur-
pose, several removable or fixed appliances have been developed [3]. However, reviews
reported very limited [4–6], partial [7] or relevant [8], [9] effectiveness of such treatment in
terms of additional mandibular growth, i.e. correction of skeletal Class II malocclusion. The
reason for this apparently inconsistent evidence might reside in the different interventions per-
formed [8], [9] in the large variation in individual responsiveness to functional treatment [10],
or in the timing, i.e. pre-pubertal or pubertal growth phase [11], during which treatment is per-
formed. Indeed, growth does not occur at a constant rate and children of the same chronologi-
cal age might not have equivalent skeletal maturity or growth potential [11]. Interestingly,
while previous reviews focused mainly on the appliance type [7], [12], none has focused on the
timing of intervention, although this issue has been raised years ago [8]. The only exception is
a recent meta-analysis [13] on fixed appliances that reported significant skeletal effects for
pubertal patients and not for post-pubertal ones.
A further ethical issue also relates to the clinical trials evaluating the effectiveness of func-
tional treatment for skeletal Class II malocclusion. Indeed, leaving subjects with relevant mal-
occlusions without orthodontic treatment during the pubertal growth phase or after, has
limited the execution of randomized clinical trials (RCTs) at this stage of development.
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Therefore, reviews including exclusively RCTs [4], [5], might have been focused mostly on pre-
pubertal subjects, leaving the potential effects of treatment on pubertal patients excluded from
the analysis. For this reason, the consideration of controlled clinical trials (CCTs) with reason-
able methodological quality has been advocated [14]. Moreover, it has been reported that
whenever RCTs are not available for meta-analysis, CCTs or observational studies may be used
with essentially similar outcomes [15].
Whether the efficiency of functional treatment for skeletal Class II malocclusion is critically
dependent on the timing of intervention has still not been clarified, especially for removable
appliances. Yet, this information would have relevant clinical implications in terms of treat-
ment planning. Therefore, the aim of the present review and meta-analysis of RCTs and CCTs
was to assess the short-term skeletal (mainly supplementary mandibular growth) and dentoal-
veolar effects of removable functional appliances for the treatment of Class II malocclusion
during the pre-pubertal or pubertal growth phase, as compared to matched untreated controls.
Materials and Methods
Search strategy
The present meta-analysis followed the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement [16] (S1 PRISMA Checklist), used a previous systematic
review as a template [13], and it has been registered at the PROSPERO database (http://www.
crd.york.ac.uk/PROSPERO). Articles were identified through a literature survey carried out
through the following databases: i) PubMed, ii) SCOPUS iii) Latin American and Caribbean
Health Sciences (LILACS), iv) Scientific Electronic Library Online (SciELO), and v) The
Cochrane Library. The survey covered the period from inceptions to the last access on May 31,
2015 with no language restrictions. The search algorithms used in each database have been
published previously [13] and are reported in Table 1. Finally, a manual search was also per-
formed by scoring the references within the studies examined and the titles of the papers pub-
lished over the last 15 years among the following major journals: i) American Journal of
Orthodontics and Dentofacial Orthopedics, ii) European Journal of Orthodontics, iii) Journal
of Orofacial Orthopedics, iv) Korean Journal of Orthodontics, v) Orthodontics and Craniofa-
cial Research; vi) Progress in Orthodontics, vii) The Angle Orthodontist, and viii) World Jour-
nal of Orthodontics. The eligibility assessment was performed independently by two blinded
authors (GP and JP). The intra-examiner reliability in the study selection process was assessed
Table 1. The search algorithms used in the literature search according to each database.
Database Algorithm Hits
Medline, Entrez PubMed www.ncbi.nlm.nih.gov "Orthodontic appliances, Functional"[Mesh] OR "Orthodontic appliances"[All Fields] OR
"functional"[All Fields] AND ("Malocclusion, Angle Class II"[Mesh] OR "jaw"[All Fields] OR
"orthop*"[All Fields]) AND (("Class"[All Fields] AND "II"[All Fields] AND "Malocclusion"[All
Fields]) OR ("Angle"[All Fields] AND "Class"[All Fields] AND "II"[All Fields]))
2,087
SCOPUS www.scopus.com TITLE-ABS-KEY(((orthodontic appliance) OR (functional jaw orthopedics)) AND ((class ii
malocclusion) OR (angle class ii))) AND (LIMIT-TO(DOCTYPE, "ar") OR LIMIT-TO
(DOCTYPE, "ip")) AND (LIMIT-TO(SUBJAREA, "DENT") OR LIMIT-TO(SUBJAREA,
"MULT"))
1,303
LILACS http://lilacs.bvsalud.org ((Orthodontic appliance) OR (Functional jaw orthopedics)) AND ((Class II malocclusion) OR
(Angle Class II))
251
Cochrane Library (Registered Controlled
trials) www.thecochranelibrary.com
((Orthodontic appliance) OR (Functional jaw orthopedics)) AND ((Class II malocclusion) OR
(Angle Class II))
215
SciELO http://www.scielo.org ((Orthodontic appliance) OR (Functional jaw orthopedics)) AND ((Class II malocclusion) OR
(Angle Class II))
28
doi:10.1371/journal.pone.0141198.t001
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through the Cohen k test assuming a threshold value of 0.61 [17]. Conflicts were resolved by
discussion of each article, until consensus was reached. An attempt to contact the correspond-
ing Authors of the included studies was made to retrieve any missing information or clarifica-
tion of specific items.
Eligibility criteria
The studies retrieved had to be RCTs or either prospective or retrospective CCTs. They had to
include healthy patients treated during the pre-pubertal or pubertal growth phases. These stud-
ies had to investigate the skeletal and dentoalveolar effects with no restriction as to the type of
parameters collected, as long as at least one of the main outcomes (see below) was included.
Also, no restrictions were set regarding the type of removable appliance whenever used alone
without any other additional therapy (fixed, extra-oral traction, etc.), treatment length or to the
cephalometric analysis used. Studies were excluded if a reliable indicator of growth phase
(hand-and-wrist maturation [HWM] method or cervical vertebral maturation [CVM] method)
was not used. Further inclusions and exclusion criteria are listed in detail in Table 2.
Data items
The following data were extracted independently by two authors (GP and JP): study design,
prospective or retrospective enrolment of the treated group, sample size, gender distribution,
age, type of functional appliance used, Class II description, indicators of skeletal maturity and
distribution of subjects according to growth phase, prognostic or other features, cephalometric
magnification factor, full treatment and observational duration, mandibular advancement for
treated patients and when treatment was stopped. Regarding the treatment effects, the follow-
ing items were also collected: success rate (as defined in different studies), skeletal,
Table 2. Inclusion and exclusion criteria used in the present review.
Inclusion criteria
1. Longitudinal studies, either prospective or retrospective, on healthy growing subjects treated for skeletal
Class II malocclusion due to mandibular retrusion
2. Use of removable functional orthodontic appliances
3. Use of a reliable indicator of individual skeletal maturity to assess treatment timing that had to be either
pre-pubertal or pubertal
4. Use of matched control groups of untreated Class II malocclusion subjects with similar growth phase
5. Reporting treatment effects data according to parameters collected before and at the end of functional
treatments
Exclusion criteria
1. Case reports, case series with no statistical analysis, comments, letters to the Editor, reviews
2. Studies using the headgear alone or in combination with other functional appliances
3. Studies in which the compared treated groups were subjected to different treatment modalities
4. Studies in which treatment length was significantly different than the observational time length of the
control group
5. Studies in which orthodontic treatment was combined with fixed appliances, mini-implants or surgery
6. Studies without cephalometric analyses or without measures defined herein as primary outcomes
7. Studies in which a favourable response to treatment (according to the Authors’ definition) was an
inclusion criterion
8. Studies in which skeletal maturation was assessed but subjects with different stages were pooled in the
same treated or control group
9. Studies in which the control group was based on published reference standards without a specific
matching of the groups by age, gender, and other features
doi:10.1371/journal.pone.0141198.t002
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dentoalveolar and soft tissues effects, and Authors’ conclusions on the growth phase and treat-
ment efficiency. Forms used for data extraction were mostly pre-defined at the protocol stage
by two authors (GP and LC).
Assessment of risk of bias in individual studies
No single approach in assessing methodological soundness may be appropriate to all system-
atic reviews [18]. Therefore, risk of bias in individual studies was assessed according to the
Cochrane Collaboration’s Tool [19] and a slightly modified Downs and Black tool [20] for ran-
domised and non-randomised trials, respectively.
The items included in the Cochrane Collaboration’s Tool [19] are defined as: sequence gen-
eration, allocation concealment, blinding, incomplete outcome data (i.e., drop-out information
or cephalometric magnification), selective outcome reporting (i.e., relevant cephalometric
parameters), and other risks of bias. In particular, the ‘other bias’ domain included a set of pre-
specified entries defined as: i) inclusion of Class II patients relying on overjet alone, which can-
not account for a true skeletal Class II malocclusion [21]; ii) lack of analysis of other potentially
relevant diagnostic/prognostic features, such as facial divergence, maxillary protrusion, or con-
dylar angle [10].
The original Downs and Black tool is calculated by rating each study across a variety of
domains including reporting (10 items), external validity (3 items), internal validity—bias (7
items), internal validity—confounding (6 items), and power (1 item) with maximum score of
32 [20]. In the present review, only minor adaptations were followed to adhere with the studies
dealing with functional treatment for Class II malocclusion. These were as follows: i) items
were added in the reporting section as: ‘Were inclusion and exclusion criteria clearly stated?’
(yes, 1 point; no or unclear, 0 points); ‘Is the Class II malocclusion fully described?’ (fully
described including skeletal parameters, or at least reporting a full molar Class II, 1 point; no, 0
points); ii) the original item #14 ‘Was an attempt made to blind study subjects to the interven-
tion they have received?’ was removed as this is not applicable; iii) the original item #20 ‘Were
the main outcome measures accurate (reliable and repeatable)?’ was used to derive 2 items for
the reliability of the skeletal maturation staging and cephalometric measurements (yes, 1 point;
no or unclear, 0 points); iii) The last item on the power was simplified as follows: ‘Prior esti-
mate of sample size’ (yes, 1 point; no or unclear, 0 points). The maximum score for this modi-
fied Downs and Black tool is thus 29.Evaluation was performed without blinding by two
Authors (GP and JP) and conflicts were resolved by discussion. A third Author (LC) was con-
sulted if necessary.
Assessment of risk of bias across studies
Heterogeneity was assessed using the χ2-based Q-statistic method with a significant p value
<0.1. However, because of the moderate insensitivity of the Q statistic [22], an I2 index was
also reported with values50% considered associated to a substantial heterogeneity among the
studies [23]. In particular, the I2 index describes the percentage of total variation across studies
due to heterogeneity rather than chance. The tau2 was also calculated for the heterogeneity
assessment. The Review Manager software version 5.2.6 (http://www.cochrane.org) was used
for the assessment of heterogeneity. Moreover, the Egger test [24] and the Begg and Mazumdar
rank correlation test [25] were employed to assess publication bias and to compensate for pos-
sible lack of power [26], with significant p value set at p<0.1. Calculations were performed
using the Comprehensive Meta-Analysis software version 2.0 (Biostat Inc., Englewood, NJ,
USA).
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Primary and secondary outcomes
For the meta-analysis, primary outcomes included those cephalometric parameters related to
mandibular growth, and expressed as supplementary growth in comparison to the untreated
controls. They were: 1) total mandibular length, 2) mandibular ramus height, 3) composite
mandibular length (according to Pancherz Analysis) [27], and 4) mandibular base (according
to Pancherz Analysis) [27]. Secondary outcomes, again as supplementary changes in compari-
son to the untreated controls, were: 1) SNA, 2) SNB and 3) ANB angles, 4) maxillary base
(according to Pancherz Analysis) [27], 5) total facial divergence, and 6) mandibular incisor
proclination (relative to the mandibular plane). Although the measures of total mandibular
length, mandibular ramus height, facial divergence, and lower incisor proclination differed
slightly among the studies, these were combined in the overall effects according to the concept
that the differences in the intra-group changes would be poorly sensitive to the absolute mea-
sures from which they are derived.
Summary measures and synthesis of results
The mean difference was used for statistical pooling of data and results were expressed as mean
and 95% confidence intervals (CIs). Moreover, 90% prediction intervals were also calculated as
previously reported [28]. Subgroup analyses were performed whenever possible according to the
growth phase, pubertal or post-pubertal, during which treatment was performed. Moreover, to
account for the heterogeneity of the treatments, i.e. differences among the appliance used, treat-
ment length, and cephalometric analysis, a random effect model was used for calculations of all
the overall effects [29]. No studies including two or more treated groups compared to a single
control group were retrieved. Finally, these analyses were reported according to the different sub-
groups of pre-pubertal and pubertal subjects and shown through forest plots. Treatment duration
was noteworthy different among the retrieved studies; therefore, when not already reported in
the articles, annualised changes for all the parameters were calculated and used for meta-analysis.
Furthermore, whenever necessary and possible, the magnification for linear parameters was set
at 0%. The ReviewManager software was used for meta-analysis (S1 Table).
Additional analysis
As for the main analyses, all the additional analyses were performed according to the pre-puber-
tal and pubertal subgroups. Robustness of the meta-analysis for each outcome was assessed by
sensitivity analysis, carried out with the Comprehensive Meta-Analysis software, that was run by
eliminating studies one-by-one, and differences in estimations above 0.5 mm (for linear out-
comes) or 0.5° (for angular outcomes) were considered as clinically relevant. Moreover, the over-
all quality of evidence for each of the primary outcomes, according to the pre-pubertal and
pubertal subgroups, was evaluated following the Grades of Recommendation, Assessment, Devel-
opment, and Evaluation (GRADE) guidelines using the GRADE profiler software version 3.6.1
(www.gradeworkinggroup.org) [30]. The GRADE assesses the quality of evidence as high, mod-
erate, low and very low based on eight different domains as follows: i) risk of bias, ii) inconsis-
tency, iii) indirectness, iv) imprecision, v) publication bias, vi) large effect, vii) plausible
confounding that would change effect, and viii) dose response gradient [31]. Although the
GRADE has been developed for RCTs, also CCTs were entered in the profiler software as rando-
mised studies, provided that they were downgraded by 1 point in the ‘risk of bias’ domain. All
the other GRADE domains were filled according to the published recommendations [30] with
the exception of the ‘large effect’ domain score that was determined on data regarding differential
growth increment in untreated Class II and Class I subjects [32]. In particular, the mean annual-
ised changes for the cephalometric measurements in the pre-pubertal and pubertal subjects were
Skeletal Maturation and Class II Treatment
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derived from this reported growth study [32]. Subsequently, 1 mmwas added to account for the
cephalometric method error, as this value may be considered representative of linear cephalomet-
ric error measurements. Therefore, by a slight excess approximation the large effects were set as
1.5 mm/year for all the primary outcomes for pre-pubertal patients, and as 2.5 mm/year for total
and composite mandibular length (Pancherz analysis), and as 2.0 mm/year and 1.5 mm/year for
the mandibular ramus height and mandibular base (Pancherz analysis), respectively, in pubertal
patients. A very large effect was set by adding 1 mm to each threshold. Moreover, due to the lack
of reporting for the composite mandibular length and mandibular base (Pancherz analysis), the
total mandibular length and Pogonion to Nasion perpendicular [32], respectively, were used
instead to elaborate dimensions of the effect.
Results
Study search
The results of the electronic and manual searches are summarised in Fig 1. According to the
electronic search, a total of 2,458 articles were retrieved. Among these, 12 studies [33–44] were
Fig 1. Flow diagram of the search strategy.
doi:10.1371/journal.pone.0141198.g001
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judged to be relevant to the present review. However, 2 articles were clearly derived from the
same study sample reporting either the results about soft tissues and SNA, SNB and ANB
angles [41] or other dentoskeletal effects [44] and may be considered as a single study. Full
details of the excluded studies at the full text analysis are reported in the Table 3. Four studies
could not be retrieved upon internet search, through the local library facility, and after having
contacted the Authors (Table 4). Finally, 1 study [40] included in the qualitative synthesis, was
not included in the meta-analysis according to the risk of bias and sensitivity analyses (see
below).
Study design and treatment interventions
Details on study designs and interventions of the included studies are summarised in Table 5.
A total of three RCTs were retrieved, including both pre-pubertal [33], [36] and pubertal [42]
subjects. Four studies [33], [36], [38], [43] included only pre-pubertal subjects, 4 more studies
[37], [39], [41], [42], [44] included only pubertal subjects, and 3 studies [34], [35], [40]
included both pre-pubertal and pubertal subjects. The enrolment of the treated group was pro-
spective in 6 studies [33], [36–38], [41], [42], [44], and retrospective in the rest of the studies.
The sample size per group ranged from a minimum of 5 [40] to a maximum of 89 [36] for
the pre-pubertal groups, and from 10 [35] to 29 [40] for the pubertal groups. The mean sub-
jects age ranged from 8.9 [43] to 10.3 [38] years for the pre-pubertal groups, and from 9.5 [37]
to 14.0 [34], for the pubertal groups. All the studies included both male and female subjects.
The removable functional appliances used were Twin-Block [34], [36], [37], [39–41], [44], Bio-
nator [33], [35], [38], Function regulator type 2 (FR-2) [43] and Sander bite jumping [42]. Two
RCTs [33], [36] assessed Class II malocclusion only on the basis of an overjet7 mm, 3 studies
[34], [35], [42] included subjects that had to have a full Class II molar relationship, the rest of
the studies [37–41], [43], [44] generally assessed Class II malocclusion by a combination of
ANB angle>4° (at least) and Class II molar relationship. To assess growth phase, 6 studies
used the CVMmethod [34–36], [38], [40], [42], while the rest used various HWMmethod
[33], [37], [39], [41], [43], [44]. Four studies, 2 on pre-pubertal [40], [43] and 2 on pubertal
subjects [40], [42], reported a normal sagittal position of the maxilla in the included patients.
One study [40] on both pre-pubertal and pubertal patients, and more 3 studies [40], [42], [44]
on pubertal patients reported an absence of vertical facial growth. The rest of the studies did
not report any further prognostic or diagnostic feature, with the exception of some dental mat-
uration stage [33] or presence of deep bite [39]. Cephalometric magnifications were set at 0%
[34–36], [40], [42], 8–9% [38], [43], or 14% [41], [44]. In the rest of the studies, information
was not provided. The mean treatment duration for the pre-pubertal subjects ranged from 1
year [40] to 2.1 years [35] with the appliance being worn at least 18 hours per day [43] to full
time wear [34], [36], [40]. However, 3 studies [33], [35], [38] on pre-pubertal subjects did not
report any information about appliance wear in terms of hours per day.
The mean treatment duration in the pubertal subjects ranged from 1 year [37] to 1.8 years
[35], with the appliance being worn at least 14 hours per day [42] to full time wear [34], [37],
[40]. Two studies [35], [39] on pubertal subjects did not report the mean appliance wear time.
In 1 study [40] including both pre-pubertal and pubertal subjects, treatment duration lasted for
1 year although post-treatment measurements were performed after an additional year of
retention. Generally, a single mandibular advancement to an incisor end-to-end relationship
was performed for overjet up to 7–10 mm; otherwise, a 2-step procedure was followed [33],
[34], [36], [37], [40], [42]. Mandibular advancement by 70% of the maximum protrusive path
was used in 1 study [41], [44]. Furthermore, a stepwise advancement of less than 3 mm was
performed in one study [43]. Other studies did not report the amount of mandibular
Skeletal Maturation and Class II Treatment
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Table 3. Studies excluded after full text consideration with corresponding main reason of exclusion.
Authors Year Reference Main Reason for exclusion
1. Jakobsson 1967 Am J Orthod 53:446–57 No skeletal maturation evaluation
2. Freunthaller 1967 Angle Orthod 37:18–22 No skeletal maturation evaluation
3. Fraenkel 1969 Am J Orthod 55:265–75 No skeletal maturation evaluation
4. Luedtke 1973 Am J Orthod 63:18–29 No skeletal maturation evaluation
5. Lewis 1976 Am J Orthod 70: 529–549 Case series
6. Bernstein et al. 1976 Am J Orthod 70:683–9 No skeletal maturation evaluation
7. Ahlgern and Laurin 1976 Br J Orthod 3:181–7 No control group
8. Bernstein et al. 1977 Am J Orthod 72: 549–559 Headgear treatment
9. Brunner 1979 Rev Orthop Dento Facial 13:269–73 Expert opinion
10. Wieslander and Lagerström 1979 Am J Orthod 79:20–6 No skeletal maturation evaluation
11. Bonnefont and Charron 1979 Rev Orthop Dento Facial 13:39–48 No skeletal maturation evaluation
12. Luder 1981 Eur J Orthod 3:205–22 No skeletal maturation evaluation
13. Baumrind and Korn 1981 Am J Orthod 80:31–47 No skeletal maturation evaluation
14. Cohen 1981 Br J Orthod 8:159–63 No skeletal maturation evaluation
15. Klaassen 1981 J Oral Surg 39:849–54 Case report
16. Luder 1982 Am J Orthod 81:390–6 No skeletal maturation evaluation
17. Calvert 1982 Br J Orthod 9:149–53 No skeletal maturation evaluation
18. Baumrind et al. 1983 Am J Orthod 84:443–65 No skeletal maturation evaluation
19. Choroschilkina and Malygin 1984 1984 Fortsch Kieferorthop 45 448–4 No skeletal maturation evaluation
20. Brieden et al. 1984 Angle Orthod 54:226–32 Not reporting primary outcomes
21. Madone and Ingervall 1984 Eur J Orthod 6:92–106 Not including a control group
22. Vargervik and Harvold 1985 Am J Orthod 88:242–51 No skeletal maturation evaluation
23. McNamara et al. 1985 Am J Orthod 88:91–110 No skeletal maturation evaluation
24. Haynes 1986 Angle Orthod 56:309–14 No skeletal maturation evaluation
25. Haynes 1986 Am J Orthod Dentofacial Orthop 90:308–20 No skeletal maturation evaluation
26. Stefani and Munster 1987 Fortschr Kieferorthop 48:154–60 Case series
27. DeVincenzo et al. 1987 Am J Orthod Dentofacial Orthop 91:213–24 No skeletal maturation evaluation
28. Fjlgen et al. 1987 Fortschr Kieferorthop 48:41–51 No skeletal maturation evaluation
29. Enlow et al. 1988 Eur J Orthod 10:192–202 No skeletal maturation evaluation
30. Falck and Frankel 1989 Am J Orthod Dentofacial Orthop 96:333–41 No skeletal maturation evaluation
31. DeVincenzo and Winn 1989 Am J Orthod Dentofacial Orthop 96:181–90 No skeletal maturation evaluation
32. Kerr et al. 1989 Eur J Orthod 11:235–42 No skeletal maturation evaluation
33. Dahan et al. 1989 Am J Orthod Dentofacial Orthop 95:127–37 No skeletal maturation evaluation
34. McNamara et al. 1990 Am J Orthod Dentofacial Orthop 98:134–44 No skeletal maturation evaluation
35. Stüber 1990 Fortschr Kieferorthop 51:361–5 No skeletal maturation evaluation
36. Jakobsson and Paulin 1990 Eur J Orthod 12:174–84 No skeletal maturation evaluation
37. Derringer 1990 Br J Orthod 17:33–46 No skeletal maturation evaluation
38. Drage and Kunt 1990 Br J Orthod 17:205–13 Limited to successful cases
39. Falck 1991 1991 Fortschr Kieferorthop 52:263–7 No skeletal maturation evaluation
40. Falck and Zimmermann 1991 1991 Fortschr Kieferorthop 52:98–101 No skeletal maturation evaluation
41. Ball and Hunt 1991 Eur J Orthod 13:53–8 No skeletal maturation evaluation
42. Ball and Hunt 1991 Eur J Orthod 13:47–52 No skeletal maturation evaluation
43. Nelson et al. 1993 Am J Orthod Dentofacial Orthop 104:153–61 No skeletal maturation evaluation
44. Vaden et al. 1995 Am J Orthod Dentofacial Orthop 107:651–61 Mixing different treatment modalities
45. Sander and Wichelhaus 1995 1995 Fortschr Kieferorthop 56:127–39 No skeletal maturation evaluation
46. Lange et al. 1995 Angle Orthod 65:423–30 No skeletal maturation evaluation
47. Webster et al. 1996 Am J Orthod Dentofacial Orthop 110:46–53 No skeletal maturation evaluation
(Continued)
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Table 3. (Continued)
Authors Year Reference Main Reason for exclusion
48. Courtney et al. 1996 Am J Orthod Dentofacial Orthop 109:616–24 No skeletal maturation evaluation
49. Battagel 1996 Eur J Orthod 18:41–54 No skeletal maturation evaluation
50. Perillo et al. 1996 Am J Orthod Dentofacial Orthop 109:132–9 No skeletal maturation evaluation
51. Kumar et al. 1996 J Clin Pediatr Dent 20:101–8 No skeletal maturation evaluation
52. Cura and Sarac 1997 Eur J Orthod 19:691–702 Mixing different treatment modalities
53. de Oliveira and de Oliveira 1997 Journal Brasileiro de Odontologia Clinica 1:51–63 No skeletal maturation evaluation
54. Illing et al. 1998 Eur J Orthod 20:501–16 No skeletal maturation evaluation
55. Mills and McCulloch 1998 Am J Orthod Dentofacial Orthop 114:15–24 No skeletal maturation evaluation
56. Lund et al. 1998 Am J Orthod Dentofacial Orthop113: 104–110 No skeletal maturation evaluation
57. Keeling et al. 1998 Am J Orthod Dentofacial Orthop 113:40–50 No skeletal maturation evaluation
58. Özbek et al. 1998 Angle Orthod 68:327–336 Unclear skeletal maturation assessment/distribution
59. Toth and McNamara 1999 Am J Orthod Dentofacial Orthop 116:597–609 No skeletal maturation evaluation
60. Tümer and Gültan 1999 Am J Orthod Dentofacial Orthop 116:460–8 Unclear skeletal maturation assessment/distribution
61. Rushfordt et al. 1999 Br J Orthod 26:127–34 No skeletal maturation evaluation
62. Lai et al. 1999 Hua Xi Kou Qiang Yi Xue Za Zhi 17:271–4 Not including a control group
63. Ehmer et al. 1999 J Orofac Orthop 60:392–408 Redundant publication
64. Mills and McCulloch 2000 Am J Orthod Dentofacial Orthop 118:24–33 Limited to successful cases
65. Trenauth 2000 Am J Orthod Dentofacial Orthop 117:54–59 No skeletal maturation evaluation
66. Trenauth et al. 2001 J Orofac Orthop 62:466–75 No skeletal maturation evaluation
67. Chadwick et al. 2001 Eur J Orthod 23:495–505 No skeletal maturation evaluation
68. Vardimon et al. 2001 Am J Orthod Dentofacial Orthop 120:416–26 No skeletal maturation evaluation
69. Eckardt et al. 2001 J Orofac Orthop 62:337–49 No skeletal maturation evaluation
70. Üçüncü et al. 2001 J Orofac Orthop 62:224–37 No skeletal maturation evaluation
71. Lux et al. 2001 Angle Orthod 71:120–6 No skeletal maturation evaluation
72. Ruf et al. 2001 Angle Orthod 71:4–11 Inappropriate control group
73. de Almeida 2001 R Dental Press Ortodon Ortop Facial 6:11–27 No skeletal maturation evaluation
74. Trenauth 2002 Eur J Orthod 24:485–91 Inappropriate control group
75. de Almeida et al. 2002 Angle Orthod 72:418–25 No skeletal maturation evaluation
76. de Almeida et al. 2002 Am J Orthod Dentofacial Orthop 121:458–66 No skeletal maturation evaluation
77. Wheeler et al. 2002 Am J Orthod Dentofacial Orthop 121:9–17 Unclear skeletal maturation assessment/distribution
78. Oliveira 2002 R Dental Press Ortodon Ortop Facial 7:55–63 No skeletal maturation evaluation
79. Janson et al. 2003 Eur J Orthod 25:301–9 No skeletal maturation evaluation
80. Basciftci et al. 2003 Eur J Orthod 25:87–93 No skeletal maturation evaluation
81. Cevidanes et al. 2003 Am J Orthod Dentofacial Orthop 123:379–87 Not reporting primary outcomes
82. Cozza et al. 2004 Angle Orthod 74:741–48 No skeletal maturation evaluation
83. Araujo et al. 2004 Am J Orthod Dentofacial Orthop 126:666–71 No skeletal maturation evaluation
84. Araujo et al. 2004 Eur J Orthod 26:515–22 No skeletal maturation evaluation
85. Cozza et al. 2004 Eur J Orthod 26:293–302 No skeletal maturation evaluation
86. Tulloch et al. 2004 Am J Orthod Dentofacial Orthop 125:657–67 Second phase of an already included study
87. Almeida et al. 2004 Eur J Orthod 26:65–72 No skeletal maturation evaluation
88. Jena et al. 2005 J Clin Pediart Dent 29:225–30 No skeletal maturation evaluation
89. Šidlauskas 2005 Stomatologija 7:7–10 No skeletal maturation evaluation
90. Cevidanes et al. 2005 Am J Orthod Dentofacial Orthop 128:16–26 Not reporting primary outcomes
91. Cevidanes et al. 2005 Am J Orthod Dentofacial Orthop 128:27–34 Not reporting primary outcomes
92. Wedler et al. 2006 J Orofac Orthop 67:105–15 No skeletal maturation evaluation
93. Türkkahraman and Özgür 2006 Eur J Orthod 28:27–34 No skeletal maturation evaluation
94. Jena et al. 2006 Am J Orthod Dentofacial Orthop 130:594–602 Not reporting primary outcomes
(Continued)
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advancement during treatment. Treatment was stopped when a Class I molar relationship [42],
[43], or a normal overjet was achieved in a mandibular retruded position [36], [41], [44]. In 1
RCT [33] treatment was performed for at least 15 months and continued if clinical objectives
were not achieved. The rest of the studies did not report when treatment was stopped.
Table 3. (Continued)
Authors Year Reference Main Reason for exclusion
95. Dolce et al. 2007 Am J Orthod Dentofacial Orthop 132:481–9 No skeletal maturation evaluation
96. Parsekian Martins et al. 2008 Am J Orthod Dentofacial Orthop 134:732–41 No skeletal maturation evaluation
97. Woods 2008 Am J Orthod Dentofacial Orthop 133:388–94 No skeletal maturation evaluation
98. Varlik et al. 2008 Eur J Orthod 30:128–34 Not reporting primary outcomes
99. O'Brien 2009 Am J Orthod Dentofacial Orthop 135:573–9 No skeletal maturation evaluation
100. Jena and Duggal 2010 Angle Orthod 80:485–91 No skeletal maturation evaluation
101. Baccetti and McNamara 2010 Prog Orthod 11:118–26 Mixing different treatment modalities
102. Siara-Olds et al. 2010 Angle Orthod 80:18–29 Unclear skeletal maturation assessment/distribution
103. Malta et al. 2010 Angle Orthod 80:10–7 Unclear skeletal maturation assessment/distribution
104. Li et al. 2010 Hua Xi Kou Qiang Yi Xue Za Zhi 28:637–40 Not reporting primary outcomes
105. Nedeljkovic 2011 Principles in Contemporary Orthodontics: 79–112 No skeletal maturation evaluation
106. Perillo et al. 2011 Eur J Pediatr Dent 12:261–6 No short term effects evaluated
107. Barros Nunes et al. 2011 Orthod Sci Pract 3:517–23 No skeletal maturation evaluation
108. Brunharo et al. 2011 Dental Press J Orthod 16:40.e1-8 Samples apparently included in another included study
109. Mahamad et al. 2012 Int J Orthod Milwaukee 23:49–58 No skeletal maturation evaluation
110. Alió-Sanz et al. 2012 Med Oral Patol Oral Cir Bucal 17:e884-92 Skeletal maturation assessment not valid
111. Alió-Sanz et al. 2012 Med Oral Patol Oral Cir Bucal 17:e689-96 Not reporting primary outcomes
112. Silvestrini-Biavati et al. 2012 Eur J Pediatr Dent 13:301–6 Unappropriated control group
113. Singh et al. 2012 J of Oral Biol Craniofac Res 2:61–66 Case series
114. Pieri et al. 2012 OrtodontiaSPO 45:525–36 Inconsistent durations of treatment and observational terms
115. Jena et al. 2013 Angle Orthod 83:728–734 No skeletal maturation evaluation
116. Antunes et al. 2013 Angle Orthod 83:455–9 Not reporting primary outcomes
117. Uzuner et al. 2014 J Orofac Orthop 75:275–86 No skeletal maturation evaluation
118. Saikoski et al. 2014 Dental Press J Orthod 19:36–45 No skeletal maturation evaluation
119. Bigliazzi et al. 2014 Angle Orthod 3 Dec Epub Not reporting primary outcomes
120. Giuntini et al. 2015 Angle Orthod 18 Mar Epub Mixing different skeletal maturation phases into same group
doi:10.1371/journal.pone.0141198.t003
Table 4. Studies that could not be retrieved for full text analysis.
1. Falck F. [Sagittal and vertical changes in mandibular retrognathism. A teleradiological longitudinal study
of patients with functional regulators compared to a control group]. Stomatol DDR. 1983;33:182–95. Article
in German.
2. Demisch A. [Long-term observation of the occlusal stability after distal bite therapy with the Bern
activator]. SSO Schweiz Monatsschr Zahnheilkd. 1980;90:867–80. Article in German.
3. Parkhonse RC. A cephalornetric appraisal of cases of Angle's Class II, division 1 malocclusion treated
by the Andresen appliance. Trans Br Soc Study Orthod1969;55:61–70.
4. Lucchese A, Carinci F, Brunelli G. Skeletal effects induced by twin block in therapy of class II
malocclusion. Eur J Inflamm; 2012;10:83–87.
The only study (Lucchese et al. 2012) for which the abstract could be retrieved examined the skeletal
effects of the Twin-Block appliance treatment in pubertal subjects, with findings similar to those of the
other investigations included herein.
doi:10.1371/journal.pone.0141198.t004
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Table 5. Protocols of the studies included in the present systematic review.
Study Study
design
Sample
size;
age in
yrs as
mean±
SD (or
range)
Appliance Class II
description
Skeletal
maturation
method/
stages
Prognostic
or other
features
Cephalometric
magnification
factor
Treatment
or
observation
duration/
Appliance
wear
Mandibular
advancement
/treatment stopped
Pre-
pubertal
subjects
Tulloch
et al. [33]
RCT 23 F; 30
M; 9.4
±1.0
Bionator Overjet7 mm HWM/ at
least 1 year
pre-peak
All
permanent
incisors and
first molars
erupted
NA 1.3 yrs/ NA 4–6 mm mandibular
advancement with
minimal vertical
opening/ At 15
months (and
continued if clinical
objectives were not
achieved)
26 F;35
M; 9.4
±1.2
Control 1.3 yrs/ —
Baccetti
et al. [34]
CCT,
R
11 F; 10
M; 9.0
±0.9
Twin-
Block
Full Class II
molar relationship
CVM/ CS 1
to 2
NA 0% 1.2 ±0.3 yrs/
Full time
Mandibular
advancement to an
incisor end-to-end
(except for patients
with overjet>7 mm in
whom 4–6 mm initial
advancement was
performed) with 5–7
mm vertical posterior
opening/ NA
7 F; 9
M; 9.1
±0.8
Control 1.3 ±0.6 yrs/
—
Faltin
et al. [35]
CCT,
R
7 F; 6
M; 9.7
±1.3
Bionator Full Class II
molar relationship
CVM/ CS 1
to 2 at end
of treatment
NA 0% 1.8 ±0.6 yrs/
NA
NA
5 F; 6M;
9.4±1.3
Control CVM/ CS 1
to 2
2.1 ±0.6 yrs/
—
O’Brien
et al. [36]
RCT 41 F; 48
M; 9.7
±0.98
Twin-
Block
Overjet >7 mm CVM/ pre-
peak
NA 0% 1.25 yrs/ Full
time
7–8 mm mandibular
advancement/ When
overjet was fully
reduced
39 F; 46
M; 9.8
±0.94
Control 1.25 yrs/ —
Almeida-
Pedrin
et al. [38]
CCT,
P
15 F;
15M;
10.35
(8.2–
11.0)
Bionator Class II/1;
bilateral molar
Class II
relationship
greater than one-
half cusp; ANB
4.5°
CVM/ CS 1
to 2
NA 9% 1.52 yrs/ NA NA
15 F;
15M;
10.0
(8.0–
10.9)
Control 1.49 yrs/ —
(Continued)
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Table 5. (Continued)
Study Study
design
Sample
size;
age in
yrs as
mean±
SD (or
range)
Appliance Class II
description
Skeletal
maturation
method/
stages
Prognostic
or other
features
Cephalometric
magnification
factor
Treatment
or
observation
duration/
Appliance
wear
Mandibular
advancement
/treatment stopped
Singh
et al. [40]
CCT,
R
5 (NA);
NA
Twin-
Block
Class II/1; Full
Class II molar
relationship on
one side and
end-on or greater
on the other side;
retrognathic
mandible; ANB
>4°
CVM/ CS 1
to 2
Normal
maxillary
position;
normal to
horizontal
growth
pattern with
little or no
vertical
problems
0% 1 yr, a/ Full
time
Mandibular
advancement of 10
mm with the
interincisal clearance
of 2 mm (except for
patients with
overjet>10 mm in
whom 7–8 mm initial
advancement was
performed, then a
second activation), a/
NA
5 (NA);
NA
Control 2 yrs/ —
Perillo
et al. [43]
CCT,
R
9 F; 8
M, a;
8.9±1.1
FR-2 Class II/1; Full or
half-cusp Class II
molar
relationship;
overjet >4 mm;
ANB >4°; SNB
<78°
MPM/ MPS
1 to 2
No maxillary
protrusion
8% 1.6 ± 0.8 yrs/
18 h per day
Mandibular
advancement less
than 3 mm/ At full
Class I molar
relationship
10 F; 7
M, a;
8.9±1.8
Control 1.6 ± 0.8 yrs/
—
Pubertal
subjects
Baccetti
et al. [34]
CCT,
R
6 F; 9
M; 12.9
±1.2
Twin-
Block
Full Class II
molar relationship
CVM/ CS 3
to 5
NA 0% 1.4 ±0.4 yrs/
Full time
Mandibular
advancement to an
incisor end-to-end
(except for patients
with overjet>7 mm in
whom 4–6 mm initial
advancement was
performed, then a
second activation).
Also, 5–7 mm
vertical posterior
opening/ NA
7 F; 7
M; 13.6
±1.2
Control 1.3 ±0.4 yrs/
—
Faltin
et al. [35]
CCT,
R
6 F; 4
M; 10.8
±1.7
Bionator Full Class II
molar relationship
CVM/ CS 3
or 4 at end
of treatment
NA 0% 2.3 ±1.5 yrs/
NA
NA
5 F; 5
M; 11.2
±1.5
Control CVM/ CS 3
or 4
1.8 ±0.7 yrs/
—
(Continued)
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Table 5. (Continued)
Study Study
design
Sample
size;
age in
yrs as
mean±
SD (or
range)
Appliance Class II
description
Skeletal
maturation
method/
stages
Prognostic
or other
features
Cephalometric
magnification
factor
Treatment
or
observation
duration/
Appliance
wear
Mandibular
advancement
/treatment stopped
Quintão
et al. [37]
CCT,P 7 F; 12
M; 9.5
±0.8
Twin
Block
Class II/1 with
distal canine and
molar
relationship;
ANB > 4
degrees;
overjet  6 mm
Epiphyseal
stages FP,
FM, G1 and
Psi
NA NA 1.0±0.08 yrs/
full time
4 mm mandibular
advancement with
re-activation after 6
months if needed/
After 12 months
7 F; 12
M; 9.9
±1.1
Control 1.0±0.08 yrs/
—
Cui et al.
[39]
CCT,
R
9 F; 18
M; 11.7
(NA)
Twin
Block
Class II/1; distal
molar
relationship;
overjet 4 mm;
ANB 5°
HWM/ NA Deep bite NA 1.2 yrs/ NA NA
9 F; 12
M; 11.3
(NA)
Control 1.2 yrs/ —
Singh
et al. [40]
CCT,
R
29 (NA);
NA
Twin-
Block
Class II/1; full
Class II molar
relationship on
one side and
end-on or greater
on the other side;
retrognathic
mandible; ANB
>4°
CVM/ CS 3
to 4
Normal
maxillary
position;
normal to
horizontal
growth
pattern with
little or no
vertical
problems
0% 1 yr, a/ Full
time
Mandibular
advancement of 10
mm with the
interincisal clearance
of 2 mm (except for
patients with
overjet>10 mm in
whom 7–8 mm initial
advancement was
performed, then a
second activation), a
/NA
29 (NA);
NA
Control 2 yrs/ —
Martina
et al. [42]
RCT 8 F; 15
M; 10.9
±1.3
Sander
Bite
Jumping
Full Class II
molar
relationship;
overjet 6 mm
CVM/ CS 3 SN-MP
angle
smaller than
normal value
±SD
0% 1.5 yrs/ 14h
per day
Initial 4 mm
mandibular
advancement
followed by individual
1.5 mm
advancements/ At
full Class I molar
relationship;
maximum treatment
duration set at 1.5
yrs
12 F; 11
M; 10.5
±1.2
Control 1 yr/—
Baysal
and
Uysal
[41], [44]
CCT,
P
10 F, 10
M; 13.0
±1.3
Twin
Block
SNB <78°; ANB
>4°; overjet 5
mm; bilateral
molar Class II
relationship (at
least 3.5 mm)
HWM/
Fourth (S
and H2) or
fifth
(MP3cap)
epiphyseal
stages
SN-GoGn
angle of 32°
±6°
14%, a 1.3 ±0.6/ Full
time
Mandibular
advancement by
70% of the maximum
protrusive path, then
a second activation/
At normal or
overcorrected overjet
(Continued)
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Main results
Main results in the included studies are summarised in Table 6. On pre-pubertal patients, 1
RCT and 1 CCT reported improvement in 75% [33] and 65% [43] of the cases. Another study
on pubertal patients reported a 100% success rate [41], [44], while in the rest of the studies the
treatment success rate was not reported. Significant skeletal effects were reported mainly in the
studies including pubertal subjects, even though 3 studies including pre-pubertal subjects
reported a significant increase of mandibular length [33], [34], or growth modification at the
maxillary level [36] that would be of poor clinical meaning. On the contrary, 3 studies includ-
ing pre-pubertal subjects reported no skeletal effects [35], [40], [43]. All the studies including
pubertal subjects reported a significant increase of mandibular length [34], [35], [37], [39–42],
[44], an opening of the gonial angle [34], [35], an increase of lower anterior facial height [40],
[41], [44], and maxillary growth restrain [41], [44]. Regardless of the growth phase, dentoal-
veolar effects were generally seen. Six studies [33–36], [40], [43] on pre-pubertal patients con-
cluded that treatment had no or minimal skeletal effects. On the contrary, 6 studies including
pubertal patients reported that optimal timing for functional treatment would be during or
slightly after the pubertal growth spurt [34], [35], [37], [40], [42]. Finally, 2 studies on pre-
pubertal [38] and pubertal patients [41], [44] did not comment on treatment timing. At the
mandibular level, these effects were reported as mesial movement of the mandibular dentition
[34–36], [38], [40], extrusion of lower first molars [38], and proclination of lower incisors [34],
[38], [39], [42]. At the maxillary level, dentoalveolar treatment effects as reclination of upper
incisors were reported both in pre-pubertal [43] and pubertal patients [37–40], [42]. One study
[34] reported distal movement of the maxillary dentition, and a further study [40] reported
absence of any dentoalveolar treatment effects for the pre-pubertal subjects. The rest of the
studies did not report information about dentoalveolar effects at the maxillary level. Modifica-
tions of the soft tissue profile were described in only 4 studies [37], [39–41], [44] on pubertal
patient as improvement of the profile, mainly due to soft tissue Pogonion advancement [37],
[40], [41], [44], upper lip retraction [37], [39], or lower lip protraction [40] were also reported.
On the contrary, 1 study [40] including pre-pubertal subjects reported no significant soft tissue
changes.
Table 5. (Continued)
Study Study
design
Sample
size;
age in
yrs as
mean±
SD (or
range)
Appliance Class II
description
Skeletal
maturation
method/
stages
Prognostic
or other
features
Cephalometric
magnification
factor
Treatment
or
observation
duration/
Appliance
wear
Mandibular
advancement
/treatment stopped
9 F, 11
M; 12.2
±1.5
Control 1.3 ±0.3 yrs/
—
RCT, randomized clinical trial; CCT, controlled clinical trial; P, prospective; R, retrospective; NA, not available; F, females; M, males; CVM, cervical
vertebral maturation; CS, CVM stage; HWM, hand-and-wrist maturation; MP3cap, medial phalanx capping stage of the third finger; FMA, Frankfurt/
mandibular plane angle; MP, mandibular plane.
a, information provided by the Authors; —, not applicable.
doi:10.1371/journal.pone.0141198.t005
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Table 6. Treatment effects in the studies included in the present systematic review.
Study Success
rate, a
Main treatment effects Conclusions on growth phase
and treatment efficiency
Skeletal Dentoalveolar Soft tissues
Pre-
pubertal
subjects
Tulloch
et al. [33]
75%
improved
cases
Significant increase in
mandibular length and
protrusion
Overjet and overbite reduction NA Early functional treatment reduces
the severity of Class II skeletal
pattern. Children with Class II
malocclusion experience
considerable variation in growth
Baccetti
et al. [34]
NA Significant mandibular length
increase and significant
opening of gonial angle
Overjet reduction, mesial movement
of maxillary and distal movement of
mandibular molars, mandibular
incisor proclination
NA Optimal timing for functional
treatment appears to be during or
slightly after the onset of the
pubertal peak
Faltin
et al. [35]
NA No significant skeletal effects Significant overjet reduction and
correction of molar relationship
NA No significant skeletal effects of
functional treatment performed
during the pre-pubertal growth
phase
O’Brien
et al. [36]
NA Significant skeletal growth
modification at maxillary and
mandibular level, however not
clinically relevant
Overjet reduction and correction of
molar relationship
NA Early functional treatment reduces
overjet in Class II malocclusion
patients mainly due to
dentoalveolar changes, with
clinically insignificant skeletal
effects
Almeida-
Pedrin
et al. [38]
NA Significant increase in
mandibular protrusion, but not
in mandibular length
Significant maxillary incisor retrusion
and reclination, and mandibular
incisor protrusion and proclination,
extrusion and mesial movement of
mandibular molars
NA None
Singh
et al. [40]
NA No significant skeletal effects No significant dental effects No significant
soft tissue
effects
Optimal timing for functional
treatment would be during or
slightly after the pubertal growth
spurt
Perillo
et al. [43]
65%, b No significant skeletal effects,
except for ANB angle reduction
Significant overjet reduction,
maxillary incisor reclination
NA Treatment at the pre-pubertal
growth phase has no mandibular
effects
Pubertal
subjects
Baccetti
et al. [34]
NA Significant mandibular length
increase and significant
opening of gonial angle
Overjet reduction, mesial movement
of maxillary and distal movement of
mandibular molars, mandibular
incisor proclination
NA Optimal timing for functional
treatment appears to be during or
slightly after the onset of the
pubertal peak
Faltin
et al. [35]
NA Significant increase in
mandibular length and ramus
height with opening of the
gonial angle
Significant overjet reduction and
correction of molar relationship with
mesial movement of the mandibular
dentition
NA Optimal timing to start functional
treatment is immediately before
the pubertal growth spurt.
Quintão
et al. [37]
NA Significant increase of
mandibular length and ANB
reduction
Upper incisor reclination and overjet
reduction
Upper lip
retraction and
forward
advancement of
soft tissue
Pogonion
A relevant degree of skeletal
correction could be obtained at
pubertal stage of development.
However, an extended growth
period would be needed for a
complete Class II correction.
Cui et al.
[39]
NA Significant increase in
mandibular length
Significant overjet reduction,
maxillary incisor reclination, lower
incisor proclination
Upper lip
retraction and
reduction of
mentolabial
sulcus angle
Functional treatment for Class II
malocclusion at the pubertal
growth spurt improves relationship
of basal bones
(Continued)
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Risk of bias in individual studies
Detailed information on the risk of bias in individual studies is shown in Tables 7 and 8 for the
RCTs and CCTs, respectively. Briefly, 2 RCTs [33], [36] had an unclear bias with regard to the
diagnosis of Class II malocclusion based on the overjet alone, while the last RCT [42] did not
show significant risk of bias. Regarding the CCTs, the overall scores ranged from 12 [40] to 24
[41], [43], [44]. Only 1 study had an overall score below the threshold and was thus judged as
affected by significant risk of bias [40], two studies [37], [39] reached 15 points, 1 study [38]
reached 16 points, 1 study [35] reached 19 points, and the last 1 study [34] reached 20 points.
Sensitivity analysis
Sensitivity analysis is detailed in Table 9. Generally, overall effects proved to be robust enough
except for the study with higher risk of bias [40]. Given the results of the sensitivity analysis
Table 6. (Continued)
Study Success
rate, a
Main treatment effects Conclusions on growth phase
and treatment efficiency
Skeletal Dentoalveolar Soft tissues
Singh
et al. [40]
NA Significant increase in
mandibular protrusion and
length; significant increase in
lower anterior facial height
Significant overjet and overbite
reduction; maxillary incisor
reclination, extrusion and mesial
movement of mandibular molars
Significant
advancement of
lower lip and soft
tissue Pogonion
Optimal timing for functional
treatment of Class II malocclusion
is during or slightly after the
pubertal growth spurt.
Martina
et al. [42]
NA Significant increase in
mandibular length
Significant overjet reduction,
maxillary incisor reclination and
mandibular incisor proclination
Treatment response was relevant
and not influenced by the cervical
stage (3 or 4) among pubertal
subjects
Baysal
and
Uysal
[41], [44]
100% Increase in composite
mandibular length, maxillary
growth restrain, significant
increase in lower anterior and
posterior face heights
Overjet reduction Significant
advancement of
soft tissue
Pogonion and
lower lip
None
NA, not available
a, as defined by the authors
b, information provided by the Authors.
doi:10.1371/journal.pone.0141198.t006
Table 7. Risk of bias for the randomised clinical trials according to the Cochrane tool.
Study Random
sequence
generation
(selection bias)
Allocation
concealment
(selection bias)
Blinding of
personnel
(performance
bias), a
Blinding of
outcome
assessment
(detection bias)
Incomplete
outcome data
(attrition bias)
Selective
reporting
(reporting
bias)
Other
bias
Overall
risk of
bias
Tulloch
et al.
[33]
Low Unclear Low Unclear Low Low Unclear, b Unclear
O’Brien
et al.
[36]
Low Low Low Low Low Low Unclear, b Unclear
Martina
et al.
[42]
Low Low Low Low Low Low Low Low
a, Even if not feasible, the risk of bias for non-blinded personnel performing the treatment was not judged as a significant risk of bias
b, Class II malocclusion determined only by overjet.
doi:10.1371/journal.pone.0141198.t007
Skeletal Maturation and Class II Treatment
PLOS ONE | DOI:10.1371/journal.pone.0141198 October 28, 2015 17 / 35
Table 8. Risk of bias for the controlled clinical trials according to the modified Downs and Black tool.
Item Baccetti
et al.
[34]
Faltin
et al.
[35]
Quintão
et al.
[37]
Almeida-
Pedrin
et al. [38]
Cui
et al.
[39]
Singh
et al.
[40]
Baysal and
Uysal [41],
[44]
Perillo
et al.
[43]
Reporting
1. Is the objective of the study clearly described? Yes Yes Yes Yes Yes Yes Yes Yes
2. Are the main outcomes to be measured clearly described
in the Introduction or Methods section (including
cephalometric magnification)?
Yes Yes No Yes Yes Yes Yes Yes
3. Were inclusion and exclusion criteria clearly stated? Yes Yes No No No Yes Yes Yes
4. Are the characteristics of the patients included clearly
described?
Yes No Yes Yes No No Yes Yes
5. Is the Class II malocclusion fully described? No No Yes Yes Yes Yes Yes Yes
6. Are the interventions of interest clearly described? Yes No Yes No No No Yes Yes
7. Are the distributors of principal confounders in each
group of subjects to be compared clearly described?
Yes Yes Partially Partially Partially No Yes Yes
8. Are the main findings of the study clearly described? Yes Yes Yes Yes Yes Yes Yes Yes
9. Does the study provide estimates of the random
variability in the data for the main outcomes?
Yes Yes Yes Yes Yes Yes Yes Yes
10. Have all important adverse events that may be a
consequence of functional appliances been reported?
Yes Yes Yes Yes Yes Yes Yes Yes
11. Have the characteristics of patients lost to follow-up
been described?
Yes Yes Yes Yes Yes Yes Yes Yes
12. Have actual probability values been reported for the
main outcomes except where the probability value is less
than 0.001?
No No No No Yes No Yes No
External validity
13. Were the patients asked to participate in the study
representative of the entire population from which they were
recruited?
Yes Yes Unclear Unclear Unclear Unclear Yes Yes
14. Were those subjects who were prepared to participate
representative of the entire population from which they were
recruited?
Unclear Unclear Unclear Unclear Unclear Unclear Yes Yes
15. Were the staff, places, and facilities where the patients
were treated, representative of the treatment the majority of
patients receive?
Yes Yes Yes Yes Yes Yes Yes Yes
Internal validity—bias
16. Was an attempt made to blind those measuring the
main outcome of the intervention?
No No Unclear Unclear Yes Yes Unclear Yes
17. If any of the results of the study were based on “data
dredging”, was that made clear?
Yes Yes Yes Yes Yes Unclear Yes Yes
18. Do the analyses adjust for different lengths of follow-up
of patients?
Yes Yes Unclear Yes Yes No Yes Yes
19. Were the statistical tests used to assess the main
outcomes appropriate?
Yes Yes No No No Unclear Yes Yes
20. Was compliance with the intervention, i.e. appliance
wear, reliable?
Yes Yes Unclear Unclear Unclear Yes Yes Yes
21. Was the skeletal maturation staging assessment
accurate (valid and reliable)?
Yes Yes Unclear Unclear Unclear Unclear Unclear No
22. Were the main outcomes measures used accurate
(valid and reliable)?
Yes Yes Yes Yes Unclear Unclear Yes Yes
Internal validity—confounding
23. Were the patients in different intervention groups
recruited from the same population?
No No Yes Yes No Unclear Unclear Yes
24. Were the baseline characteristics comparable? Yes Yes Yes Yes Yes Unclear Yes Yes
(Continued)
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combined with the overall risk of bias, 1 CCT [40] was excluded from the meta-analyses and
GRADE assessment reported below. One study [40] uncovered a relevant effect at the sensitiv-
ity analysis. Regarding the pubertal subgroup, the overall (for all studies) total mandibular
length and mandibular ramus showed about 0.8 mm difference with the corresponding values
without the study with the highest risk of bias assessment [40]. Similarly, clinically relevant
effects were seen when removing the same study [40] for the ANB angle and facial divergence.
Of note the mandibular incisor proclination also yielded some different estimations between
all the studies when a RCT [42] was removed.
Risk of bias among studies
Heterogeneity at the subgroup level was generally low, with I2 values between 0% and 56% for
all the primary outcomes (Figs 2–5). On the contrary, substantial heterogeneity was seen for
the SNA, SNB, ANB angles with I2 values up to 88% (ANB angle, pubertal subgroup) as shown
in Figs 6–8. The maxillary base (Pancherz Analysis) and facial divergence showed no or accept-
able heterogeneity with I2 values equal to 0 in both subgroups (Fig 9) or not exceeding 55%
(Fig 10), respectively. Finally, lower incisor proclination also showed acceptable heterogeneity
with I2 values not exceeding 47% in both subgroups (Fig 11). Results on the publication bias
analyses are shown in Table 10. Generally non-significant p values were seen for all the param-
eters in both subgroups. Exception were seen for the SNB and ANB angles that yielded a signif-
icant publication bias according to the Egger test in the pubertal subgroup (p = 0.020 and
p = 0.056, respectively), for the ANB for the pre-pubertal subgroup (p = 0.055), and for the
facial divergence for the pre-pubertal subgroup (p = 0.089).
Meta-analysis for the primary outcomes
The cephalometric measurements used in each study and pooled herein for the meta-analysis
are reported in Table 11. Detailed results for the meta-analysis for the primary outcomes are
shown in Figs 2–5. Overall effects are expressed as mean (95% confidence interval) with 90%
prediction intervals summarised in Table 12. For the total mandibular length, no study made
use of the Articulare as the endpoint. The overall annualised changes were 0.95 mm (0.38,
1.51) and 2.91 mm (2.04, 3.79) in the pre-pubertal and pubertal subgroups, respectively. The
difference between the subgroups was significant at p<0.01 (Fig 2). The prediction intervals of
the annualised changes ranged from -0.30 to 2.20 mm and from 1.04 to 4.78 mm in the pre-
pubertal and pubertal subgroups, respectively. Regarding the mandibular ramus height, the
overall annualised change in pre-pubertal patients was 0.00 mm (-0.52, 0.53). While in pubertal
Table 8. (Continued)
Item Baccetti
et al.
[34]
Faltin
et al.
[35]
Quintão
et al.
[37]
Almeida-
Pedrin
et al. [38]
Cui
et al.
[39]
Singh
et al.
[40]
Baysal and
Uysal [41],
[44]
Perillo
et al.
[43]
25. Were study subjects in different intervention groups
recruited over the same period of time?
No No Unclear No Unclear Unclear Unclear No
26. Was there adequate adjustment for confounding in the
analyses from which the main findings were drawn?
No No No No No No No No
27. Were losses of patients to follow-up taken into account? Yes Yes Yes Yes Yes Yes Yes Yes
Power
28. Prior estimate of sample size No No No No No No Yes Yes
Total 20 19 15 16 15 12 24 24
doi:10.1371/journal.pone.0141198.t008
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Table 9. Results of the sensitivity analyses for each of the included parameter according to the pre-pubertal and pubertal subgroups.
Variable Subgroup Removed study Mean Difference [95% CI]
Total mandibular length (mm) Pre-pubertal Tulloch et al. [33] 0.71 [0.18, 1.23]
Baccetti et al. [34] 0.97 [0.60, 1.34]
Faltin et al. [35] 1.08 [0.71, 1.46]
Almeida-Pedrin et al. [38] 1.12 [0.74, 1.51]
Singh et al. [40] 1.05 [0.69, 1.41]
Perillo et al. [43] 1.17 [0.79, 1.55]
All studies 1.04 [0.69, 1.4]
Pubertal Baccetti et al. [34] 3.67 [3.17, 4.16]
Faltin et al. [35] 3.87 [3.40, 4.35]
Quintão et al. [37] 3.88 [3.40, 4.36]
Cui et al. [39] 3.91 [3.42, 4.40]
Singh et al. [40] 2.95 [2.33, 3.57], a
Baysal and Uysal [41], [44] 4.05 [3.55, 4.55]
Martina et al. [42] 3.91 [3.42, 4.41]
All studies 3.8 [3.33, 4.26]
Mandibular ramus height (mm) Pre-pubertal Baccetti et al. [34] -0.06 [-0.65, 0.52]
Faltin et al. [35] 0.00 [-0.58, 0.58]
Singh et al. [40] 0.00 [-0.52, 0.52]
Perillo et al. [43] 0.21 [-0.43, 0.85]
All studies 0.03 [-0.47, 0.53]
Pubertal Baccetti et al. [34] 2.91 [2.44, 3.39]
Faltin et al. [35] 2.95 [2.48, 3.41]
Singh et al. [40] 2.17 [1.50, 2.84], a
Baysal and Uysal [41], [44] 3.07 [2.57, 3.57]
Martina et al. [42] 3.02 [2.56, 3.49]
All studies 2.90 [2.45, 3.34]
Composite mandibular length (mm) Pre-pubertal Baccetti et al. [34] 0.94 [0.18, 1.69]
Faltin et al. [35] 1.21 [0.41, 2.01]
O'Brien et al. [36] 0.47 [-0.69, 1.63]
All studies 0.96 [0.25, 1.66]
Pubertal Baccetti et al. [34] 1.77 [1.00, 2.55]
Faltin et al. [35] 2.36 [1.62, 3.10]
Baysal and Uysal [41], [44] 2.42 [1.59, 3.25]
Martina et al. [42] 1.99 [1.12, 2.86]
All studies 2.14 [1.45, 2.83]
Mandibular base (mm) Pre-pubertal Baccetti et al. [34] 0.77 [0.10, 1.44]
Faltin et al. [35] 1.00 [0.28, 1.71]
O'Brien et al. [36] 1.22 [0.07, 2.38]
All studies 0.93 [0.29, 1.56]
Pubertal Baccetti et al. [34] 1.51 [0.94, 2.07]
Faltin et al. [35] 1.75 [1.20, 2.30]
Baysal and Uysal [41], [44] 1.69 [0.96, 2.43]
Martina et al. [42] 1.58 [0.93, 2.24]
All studies 1.63 [1.10, 2.16]
SNA angle (°) Pre-pubertal Tulloch et al. [33] 0.02 [-0.30, 0.340]
Almeida-Pedrin et al. [38] -0.14 [-0.49, 0.20]
Singh et al. [40] -0.02 [-0.29, 0.25]
(Continued)
Skeletal Maturation and Class II Treatment
PLOS ONE | DOI:10.1371/journal.pone.0141198 October 28, 2015 20 / 35
Table 9. (Continued)
Variable Subgroup Removed study Mean Difference [95% CI]
Perillo et al. [43] -0.03 [-0.33, 0.26]
All studies -0.04 [-0.30, 0.22]
Pubertal Quintão et al. [37] -0.42 [-0.73, -0.11]
Cui et al. [39] -0.49 [-0.81, -0.18]
Singh et al. [40] -0.63 [-0.98, -0.28]
Baysal and Uysal [41], [44] -0.16 [-0.59, 0.27]
All studies -0.45 [-0.75, -0.16]
SNB angle (°) Pre-pubertal Tulloch et al. [33] 0.49 [0.19, 0.79]
Almeida-Pedrin et al. [38] 0.43 [0.17, 0.69]
Singh et al. [40] 0.58 [0.35, 0.81]
Perillo et al. [43] 0.70 [0.45, 0.95]
All studies 0.56 [0.33, 0.78]
Pubertal Quintão et al. [37] 1.92 [1.57, 2.26]
Cui et al. [39] 2.00 [1.64, 2.37]
Singh et al. [40] 1.00 [0.60, 1.39], a
Baysal and Uysal [41], [44] 2.09 [1.69, 2.50]
All studies 1.77 [1.44, 2.09]
ANB angle (°) Pre-pubertal Tulloch et al. [33] -0.71 [-1.01, -0.42]
Almeida-Pedrin et al. [38] -0.74 [-1.00, -0.47]
Singh et al. [40] -0.73 [-0.95, -0.51]
Perillo et al. [43] -0.76 [-0.99, -0.52]
All studies -0.73 [-0.95, -0.52]
Pubertal Quintão et al. [37] -2.10 [-2.42, -1.77]
Cui et al. [39] -2.14 [-2.46, -1.82]
Singh et al. [40] -1.55 [-1.89, -1.22]
Baysal and Uysal [41], [44] -1.94 [-2.29, -1.58]
All studies -1.94 [-2.23, -1.65]
Maxillary base (mm) Pre-pubertal Baccetti et al. [34] -0.72 [-1.11, -0.34]
Faltin et al. [35] -0.59 [-0.98, -0.19]
O'Brien et al. [36] -0.47 [-1.10, 0.16]
All studies -0.63 [-0.98, -0.27]
Pubertal Baccetti et al. [34] -0.46 [-0.84, -0.08]
Faltin et al. [35] -0.57 [-0.95, -0.20]
Baysal and Uysal [41], [44] -0.33 [-0.85, 0.19]
Martina et al. [42] -0.52 [-0.89, -0.15]
All studies -0.49 [-0.84, -0.15]
Facial divergence (°) Pre-pubertal Baccetti et al. [34] 0.04 [-0.30, 0.37]
Faltin et al. [35] 0.03 [-0.31, 0.37]
Almeida-Pedrin et al. [38] -0.02 [-0.40, 0.36]
Singh et al. [40] 0.16 [-0.17, 0.49]
Perillo et al. [43] 0.38 [-0.02, 0.79]
All studies 0.11 [-0.21, 0.42]
Pubertal Baccetti et al. [34] 1.54 [1.13, 1.94]
Faltin et al. [35] 1.58 [1.17, 1.99]
Cui et al. [39] 1.52 [1.12, 1.93]
Singh et al. [40] 0.80 [0.33, 1.26], a
Baysal and Uysal [41], [44] 1.66 [1.25, 2.06]
(Continued)
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patients, the overall annualised change was 2.18 mm (1.51, 2.86). The difference between the
subgroups was significant at p<0.01 (Fig 3). The prediction intervals of the annualised changes
ranged from -1.69 to 1.69 mm and from 1.17 to 3.19 mm in the pre-pubertal and pubertal sub-
groups, respectively. For the composite mandibular length, the overall annualised change in
pre-pubertal patients was 0.94 mm (0.25, 1.63), while in pubertal patients, the overall annual-
ised change was 2.10 mm (1.02, 3.18). The difference between the subgroups was not signifi-
cant even though the p value was close to significance at 0.08 (Fig 4). The prediction intervals
of the annualised changes ranged from -1.28 to 3.16 mm and from -0.78 to 4.98 mm in the pre-
pubertal and pubertal subgroups, respectively. Regarding the mandibular base (Pancherz Anal-
ysis), the overall annualised change in pre-pubertal patients was 1.01 mm (0.21, 1.80), while in
Table 9. (Continued)
Variable Subgroup Removed study Mean Difference [95% CI]
Martina et al. [42] 1.53 [1.13, 1.93]
All studies 1.46 [1.09, 1.84]
Mandibular incisors proclination (°) Pre-pubertal Almeida-Pedrin et al. [38] 1.64 [0.02, 3.27]
Singh et al. [40] 1.37 [0.38, 2.36]
Perillo et al. [43] 1.17 [0.02, 2.32]
All studies 1.35 [0.39, 2.31]
Pubertal Cui et al. [39] 0.94 [-0.20, 2.08]
Singh et al. [40] 0.72 [-0.32, 1.77]
Baysal and Uysal [41], [44] 1.01 [-0.28, 2.30]
Martina et al. [42] 0.17 [-0.95, 1.29], a
All studies 0.69 [-0.29, 1.68]
Note of judgments:
a, value with clinical relevant difference as compared to the corresponding overall (all studies) mean.
doi:10.1371/journal.pone.0141198.t009
Fig 2. Forest plots for the annualised changes in total mandibular length according to the pre-pubertal and pubertal subgroups.
doi:10.1371/journal.pone.0141198.g002
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pubertal patients, the overall annualised change was 1.63 mm (0.98, 2.28), without significant
differences between subgroups (p = 0.24; Fig 3). The prediction intervals of the annualised
changes ranged from -2.47 to 4.49 mm and from 0.26 to 3.00 mm in the pre-pubertal and
pubertal subgroups, respectively.
Meta-analysis for the secondary outcomes
The cephalometric measurements used in each study, and pooled herein for the meta-analysis
are reported in Table 11. Detailed results for the meta-analysis are shown in Figs 6–11 for the
secondary outcomes with 90% prediction intervals summarised in Table 12. Overall effects are
expressed as mean (95% confidence interval). For the SNA angle, the overall annualised change
in pre-pubertal patients was -0.02° (-0.29, 0.25). While in pubertal patients, the overall
Fig 3. Forest plots for the annualised changes in mandibular ramus height according to the pre-pubertal and pubertal subgroups.
doi:10.1371/journal.pone.0141198.g003
Fig 4. Forest plots for the annualised changes in composite mandibular length (Pancherz analysis) according to the pre-pubertal and pubertal
subgroups.
doi:10.1371/journal.pone.0141198.g004
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annualised change was -0.05° (-1.02, 0.08), but the difference between the two subgroups was
not significant at p = 0.15, and the I2 values were 0% and 56% for the pre-pubertal and pubertal
subgroups, respectively (Fig 6). The prediction intervals of the annualised changes ranged from
-0.89° to 0.85° and from -3.35° to 2.41° in the pre-pubertal and pubertal subgroups, respec-
tively. Regarding the SNB angle, the overall annualised change in pre-pubertal patients was
0.56° (0.11, 1.01) and of 1.00° (0.60, 1.39) in pubertal patients, with no significant (p = 0.15)
differences between the subgroups, and the I2 values were 72% and 0% for the pre-pubertal and
pubertal subgroups, respectively (Fig 7). The prediction intervals of the annualised changes
ranged from -2.06° to 3.18° and from -0.27° to 2.27° in the pre-pubertal and pubertal sub-
groups, respectively. For the ANB angle, the overall annualised change in pre-pubertal patients
was -0.73° (-0.95, -0.50) while, in pubertal patients, the overall annualised change was -2.14°
(-3.09, -1.18). The difference between the subgroups was significant at p<0.01, and the I2 val-
ues were 0% and 88% for the pre-pubertal and pubertal subgroups, respectively (Fig 8). The
Fig 5. Forest plots for the annualised changes in mandibular base (Pancherz analysis) according to the pre-pubertal and pubertal subgroups.
doi:10.1371/journal.pone.0141198.g005
Fig 6. Forest plots for the annualised changes in SNA angle according to the pre-pubertal and pubertal subgroups.
doi:10.1371/journal.pone.0141198.g006
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prediction intervals of the annualised changes ranged from -1.45° to -0.01° and from -8.02° to
3.74° in the pre-pubertal and pubertal subgroups, respectively. Regarding the Maxillary base
(Pancherz Analysis), the overall annualised change in pre-pubertal patients was -0.62 mm
(-0.97, -0.27) and -0.49 mm (-0.84, -0.15) in pubertal patients. The difference between the sub-
groups was not significant at p = 0.66, and the I2 values were 0% for both the subgroups (Fig 9).
The prediction intervals of the annualised changes ranged from –1.75 to 0.51 mm and from
-1.00 to 0.02 mm in the pre-pubertal and pubertal subgroups, respectively. For the facial diver-
gence, the overall annualised change in pre-pubertal patients was 0.27° (-0.25, 0.79), while in
pubertal patients, the overall annualised change was 0.80° (0.34, 1.26). The difference between
the subgroups was not significant at p = 0.14, and the I2 values were 55% and 0% for the pre-
pubertal and pubertal subgroups, respectively (Fig 10). The prediction intervals of the annual-
ised changes ranged from -1.10° to 1.64° and from -0.25° to 1.35° in the pre-pubertal and
Fig 7. Forest plots for the annualised changes in SNB angle according to the pre-pubertal and pubertal subgroups.
doi:10.1371/journal.pone.0141198.g007
Fig 8. Forest plots for the annualised changes in ANB angle according to the pre-pubertal and pubertal subgroups.
doi:10.1371/journal.pone.0141198.g008
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pubertal subgroups, respectively. Finally, for the mandibular incisor proclination, the overall
annualised change in pre-pubertal patients was 1.37° (0.38, 2.36) and 0.79° (-0.66, 2.25) in
pubertal patients. The difference between the subgroups was not significant at p = 0.52, and the
I2 values were 0% and 47% for the pre-pubertal and pubertal subgroups, respectively (Fig 11).
The prediction intervals of the annualised changes was not derivable for the pre-pubertal
patients, while for the pubertal patients ranged from -6.49° to 8.07°.
GRADE Assessment
The GRADE assessment for each of the primary outcome with detailed information is shown
in Table 13. For the pre-pubertal patients, the quality of evidence was low for all the outcomes.
Fig 9. Forest plots for the annualised changes in maxillary base (Pancherz analysis) according to the pre-pubertal and pubertal subgroups.
doi:10.1371/journal.pone.0141198.g009
Fig 10. Forest plots for the annualised changes in facial divergence according to the pre-pubertal and pubertal subgroups.
doi:10.1371/journal.pone.0141198.g010
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For the pubertal patients, the overall quality was between low (composite mandibular length)
to moderate (for all the other outcomes). Reasons for downgrading were related to the items
‘risk of bias’ (use of CCT, historical controls, and other bias as stated above) and ‘imprecision’
Fig 11. Forest plots for the annualised changes in mandibular incisor proclination according to the pre-pubertal and pubertal subgroups.
doi:10.1371/journal.pone.0141198.g011
Table 10. The p values of the Egger regression intercept test and Begg andMazumdar rank correlation test on the on the publication bias analyses
for each of the included parameter according to the pre-pubertal and pubertal subgroups.
Variable Subgroup Test
Egger Begg and Mazumdar
Total mandibular length Pre-pubertal 0.467 1.000
Pubertal 0.551 0.452
Mandibular ramus height Pre-pubertal 0.213 1.000
Pubertal 0.717 0.734
Composite mandibular length Pre-pubertal 0.646 1.000
Pubertal 0.752 0.734
Mandibular base Pre-pubertal 0.472 0.296
Pubertal 0.750 1.000
SNA Pre-pubertal 0.706 1.000
Pubertal 0.798 1.000
SNB Pre-pubertal 0.816 1.000
Pubertal 0.020, a 0.296
ANB Pre-pubertal 0.055, a 0.296
Pubertal 0.056, a 0.296
Maxillary base Pre-pubertal 0.296 0.603
Pubertal 0.278 0.308
Facial divergence Pre-pubertal 0.193 0.089, a
Pubertal 0.643 0.806
Mandibular incisor proclination Pre-pubertal — —
Pubertal 0.628 1.000
Publication bias analysis does not include the study by Singh et al. [40] excluded according to the risk of bias and sensitivity analyses. Further notes:
a, significant p value denoting publication bias; —, p value not derivable since only 2 studies were included.
doi:10.1371/journal.pone.0141198.t010
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(according to the heterogeneity seen) and for inclusion of small studies. No downgrading was
assessed for the inconsistency, indirectness or publication bias (according to the results of the
analyses reported above). Finally, upgrading mainly responsible for the greater quality seen in
the pubertal subgroup as compared to the pre-pubertal one was due to the dimension of the
treatment effect for total mandibular length, mandibular ramus height and mandibular base
that reached a ‘large effect’.
Discussion
The present review allowed the comparison of the effects of functional treatment of skeletal
Class II malocclusion by removable appliances between pre-pubertal and pubertal patients.
Study designs and main results at the skeletal, dentoalveolar and soft tissue levels were
reviewed. Moreover, cephalometric parameters, mainly regarding mandibular growth, were
meta-analysed. Overall, taking into account relevant individual variations, the present results
demonstrate clinically relevant skeletal effects in terms of additional mandibular growth only if
treatment is performed during the pubertal growth phase.
Table 11. The cephalometric measurements that were pooled for the meta-analyses.
Study Total
mandibular
length (mm)
Mandibular
ramus height
(mm)
Composite mandibular
length (Pancherz
analysis, mm)
Mandibular base
(Pancherz
analysis, mm)
Maxillary base
(Pancherz
analysis, mm)
Facial
divergence
(°)
Mandibular
incisors
proclination (°)
Tulloch
et al. [33]
Md unit
length, a
NA NA NA NA NA NA
Baccetti
et al. [34]
Co-Pg Co-Go Pg/OLp + Co/OLp Pg/OLp A point/OLp ml/FMN-T
line
NA
Faltin et al.
[35]
Co-Pg Co-Go Pg/OLp + Co/OLp Pg/OLp A point/OLp ml/FMN-T
line
NA
O'Brien
et al. [36]
NA NA Pg/OLp + Co/OLp Pg/OLp A point/OLp NA NA
Quintão
et al. [37]
Co-Gn NA NA NA NA NA NA
Almeida-
Pedrin et al.
[38]
Co-Gn NA NA NA NA SN.GoGn IMPA
Cui et al.
[39]
Co-Gn NA NA NA NA NA L1-MP
Singh et al.
[40]
Cd-Gn Cd-Go NA NA NA FMA LI-MnP
Baysal and
Uysal [41],
[44]
Co-Gn Co-Go Pg/OLp + Co/OLp Pg/OLp A point/OLp SN-GoGn IMPA
Martina
et al. [42]
Co-Pg Co-Go Pg/OLp + Co/OLp Pg/OLp Ss point/OLp SN-MP IMPA
Perillo et al.
[43]
Co-Gn Co-Go, b NA NA NA FH-MP L1/MP
Co or Cd, Condylion; Go, Gonion; Gn, Gnathion; Pg, Pogonion; Md, mandibular; MP or MnP, mandibular plane; ml, mandibular line; FMN, fronto-maxillo-
nasal suture; FH, Frankfurt horizontal; L1 or LI or 1-, mandibular incisor axis; IMPA, lower incisor mandibular plane angle; NA, not available. Pancherz
analysis according to a previous report [27]. Further notes:
a, reference points not provided
b, data provided by the Authors.
doi:10.1371/journal.pone.0141198.t011
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In spite of the large number of studies initially retrieved (Fig 1), most of them analysed in
full-text were excluded because they did not consider a reliable indicator of skeletal maturity,
or because they lacked of an untreated Class II control group (Table 3). Interestingly, a relevant
RCT on pubertal subjects [42] was missed in one of the most recent meta-analyses [6].
Even though different treatment modalities were followed in the included studies (and after
removal of a low quality investigation [40], heterogeneity among the studies was acceptable
with I2 mostly below 50% for the primary outcomes and some secondary outcomes (Figs 2–5)
with consistent results. On the contrary, SNA, SNB and ANB angles showed substantial hetero-
geneity. Of note, heterogeneity seen herein at the subgroup level for the main outcomes was
generally below those reported in other similar investigations [12] where the growth phase was
not considered as a clustering factor. Therefore, the different growth phase may explain part of
the heterogeneity (and apparent inconsistency of the results) previously reported.
Herein, clinically relevant effects in terms of additional mandibular elongation was see for
the pubertal patients of 2.91 mm/year (Fig 2). Similar clinically relevant results were seen
herein for the additional increment of the mandibular ramus height (Fig 3). However, different
removable appliances may have differentmodus operandi requiring differential treatment
duration. A previous meta-analysis [4] reported no significant effects of functional treatment
in Class II patients. This meta-analysis used standardised mean differences (obtained merging
several parameters) for the estimation of the overall effects. However, while standardised mean
differences may give an indication of the variability among individuals, they do not describe
Table 12. The 95% Prediction intervals for each of the included parameter according to the pre-puber-
tal and pubertal subgroups.
Variable Subgroup (n of studies) Point estimate [90% PI)
Primary outcome
Total mandibular length (mm) Pre-pubertal (5) 0.95 [-0.30, 2.20]
Pubertal (6) 2.91 [1.04, 4.78]
Mandibular ramus height (mm) Pre-pubertal (3) 0.00 [-1.69, 1.69]
Pubertal (4) 2.18 [1.17, 3.19]
Composite mandibular length (mm) Pre-pubertal (3) 0.94 [-1.28, 3.16]
Pubertal (4) 2.10 [-0.78, 4.98]
Mandibular base (mm) Pre-pubertal (3) 1.01 [-2.47, 4.49]
Pubertal (4) 1.63 [0.26, 3.00]
Secondary outcome
SNA angle (°) Pre-pubertal (3) -0.02 [-0.89, 0.85]
Pubertal (3) -0.47 [-3.35, 2.41]
SNB angle (°) Pre-pubertal (3) 0.56 [-2.06, 3.18]
Pubertal (3) 1.00 [-0.27, 2.27]
ANB angle (°) Pre-pubertal (3) -0.73 [-1.45, -0.01]
Pubertal (3) -2.14 [-8.02, 3.74]
Maxillary base (mm) Pre-pubertal (3) -0.69 [-1.75, 0.51]
Pubertal (4) -0.49 [-1.00, 0.02]
Facial divergence (°) Pre-pubertal (4) 0.27 [-1.10, 1.64]
Pubertal (5) 0.80 [0.25, 1.35]
Mandibular incisors proclination (°) Pre-pubertal (2) 1.37 [––,––]
Pubertal (3) 0.79 [-6.49, 8.07]
PI, prediction intervals, —, prediction interval not derivable since only 2 studies were included. Refer to
Figs 2–11 for studies included in each subgroup analysis.
doi:10.1371/journal.pone.0141198.t012
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the magnitude of the effect. Further meta-analyses reported some skeletal effects for functional
treatment of Class II malocclusion by the use of the Functional Regulator-2 [12] and Twin-
Block [7], even though the Authors were not conclusive in terms of treatment efficiency. On
the contrary, the results of the present study on pubertal patients may be compared with those
from a recent meta-analysis [13] on fixed functional appliance where the mean additional
mandibular (total length) growth as compared to matched untreated subjects was about 2 mm.
Even though this previous meta-analysis did not report annualised changes it might be
hypothesised that, irrespective of the fixed or removable appliance used, skeletal effects are
dependent on the growth phase (pubertal) during which treatment is performed.
Of note, a noteworthy individual variation in terms of treatment responsiveness was also seen
in pubertal patients particularly for the annualised total mandibular length increment (prediction
Table 13. The GRADE assessment for each of the primary outcomes, according to the pre-pubertal and pubertal subgroups.
Outcomes No of
Participants/
studies/
Follow up
Quality of the
evidence (GRADE)
Anticipated absolute effects
Risk with Control Risk difference with functional treatment
(95% CI)
Pre-pubertal
subjects
Total mandibular
length
269/ 5 studies/
1.0–1.8 years
LOW a,b - due to risk of
bias, imprecision
The mean total mandibular length
ranged across control groups from 2.02
to 3.07 mm
The mean total mandibular length in the
intervention groups was 0.95 higher (0.38 to
1.51 higher)
Mandibular ramus
height
135/ 3 studies/
1.0–1.8 years
LOW c,d—due to risk
of bias, imprecision
The mean mandibular ramus height
ranged across control groups from 1.25
to 1.73 mm
The mean mandibular ramus height in the
intervention groups was 0.00 higher (0.52
lower to 0.53 higher)
Composite
mandibular length
(Pancherz
analysis)
208/ 3 studies/
1.0–1.8 years
LOW a,d—due to risk
of bias, imprecision
The mean composite mandibular length
(Pancherz analysis) ranged across
control groups from 1.44 to 2.74 mm
The mean composite mandibular length
(Pancherz analysis) in the intervention
groups was 0.94 higher (0.25 to 1.63
higher)
Mandibular base
(Pancherz
analysis)
208/ 3 studies/
1.0–1.8 years
LOW a,b - due to risk of
bias, imprecision
The mean mandibular base (Pancherz
analysis) ranged across control groups
from 1.45 to 2.02 mm
The mean mandibular base (Pancherz
analysis) in the intervention groups was 1.01
higher (0.21 to 1.8 higher)
Pubertal subjects
Total mandibular
length
221/ 6 studies/
1.0–2.3 years
MODERATE b,c,e -
due to risk of bias,
imprecision, large effect
The mean total mandibular length
ranged across control groups from 1.66
to 3.14 mm
The mean total mandibular length in the
intervention groups was 2.91 higher (2.04 to
3.79 higher)
Mandibular ramus
height
132/ 4 studies/
1.0–2.3 years
MODERATE a,d,f - due
to risk of bias,
imprecision, large effect
The mean mandibular ramus height
ranged across control groups from 0.46
to 2.23 mm
The mean mandibular ramus height in the
intervention groups was 2.18 higher (1.51 to
2.86 higher)
Composite
mandibular length
(Pancherz
analysis)
135/ 4 studies/
1.0–2.3 years
LOW a,b - due to risk of
bias, imprecision
The mean composite mandibular length
(Pancherz analysis) ranged across
control groups from 1.11 to 1.95 mm
The mean composite mandibular length
(Pancherz analysis) in the intervention
groups was 2.10 higher (1.02 to 3.18
higher)
Mandibular base
(Pancherz
analysis)
135/ 4 studies/
1.0–2.3 years
MODERATE a,b,g—
due to risk of bias,
imprecision, large effect
The mean mandibular base (Pancherz
analysis) ranged across control groups
from 0.90 to 1.43 mm
The mean mandibular base (Pancherz
analysis) in the intervention groups was 1.63
higher (0.98 to 2.28 higher)
CI, confidence interval. Notes on the GRADE assessment:
a, only 1 randomised study, historical controls, other less relevant biases
b, different treatment durations/observation, modest heterogeneity, 1 small study
c, no randomised study, historical controls, other less relevant biases
c, different treatment durations/observation, 1 small study
e, additional mandibular elongation above 2.5 mm/year
f, additional mandibular elongation above 2.0 mm/year
doi:10.1371/journal.pone.0141198.t013
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interval from 1.04 to 4.78 mm, Table 12). In this regard, individual variations has been previously
reported in pubertal Class II patients treated by functional appliances with the condylar angle as
one of the prognostic feature [10]. Interestingly, none of the included studies herein has classified
patients according to this prognostic feature (Table 5). However, the present meta-analysis may
not discriminate whether such individual variation in treatment effects was due to the different
treatment protocols, patient’s compliance or biological individual responsiveness. In spite of
these aspects, the present results would be consistent with previous findings reporting insulin
growth factor 1 among the key factors promoting chondrogenesis of the condylar cartilage [45],
the serum levels of which would be to be significantly greater in the pubertal as compared to pre-
pubertal subjects, as determined though the CVMmethod [46], [47].
While a relevant ‘headgear’ effect has been reported for the fixed functional appliances used
during the pubertal growth phase [13], herein, irrespective of the growth phase of the patients,
a limited maxillary growth restrain (Figs 6 and 9, Table 12) was seen. Taking also into account
previous findings [7], it may be hypothesised that removable and fixed functional appliances
have different effects on maxillary bone.
An increase in facial divergence was not seen herein (Fig 10, Table 12) while, a slightly
greater (although not significant) mandibular incisors proclination was seen for pre-pubertal
patients (Fig 11, Table 12). However, this proclination appears to be of limited clinical rele-
vance in either pre-pubertal or pubertal patients. On the contrary, increase in both these
parameters have been reported earlier for the Twin-Block treatment [7]. The individual man-
agement of the dentition, i.e. extrusion of mandibular teeth, during treatment may explain at
least part of this apparent inconsistency.
Limitations of the review
The current investigation on the effects of functional treatment of Class II malocclusion is
inherently hampered by some factors. In spite of the use of annualised changes, observational
terms may include not only the effective functional treatment, but also variable periods of time
of retention, or of further management of the dentition. Therefore, skeletal changes might
occur not uniformly during the entire observational term skewing the analysis of treatment
outcomes [5]. The studies included were mostly CCTs, and in 5 studies treated groups followed
a retrospective enrolment of the treated group [34], [35], [39], [40], [43] (Table 5). Hardly to
be avoided, heterogeneity of the selected studies was mainly seen in the treatment duration,
type of appliance used (even though they all share the mechanism of forward posturing of the
mandible), or severity of malocclusion (Table 5). Moreover, 2 studies [33], [36] used overjet as
the only diagnostic criterion for Class II malocclusion, even though in 1 study [33], likely most
of the patients had a skeletal Class II malocclusion according to mean ±SD of ANB angle of
*6.3° ±2.0°. One study [40] was judged to be affected by a significant risk of bias (Table 8) and
had to be excluded from the meta-analysis. Some of the included studies had small sample
sizes [35], [40], and in 2 studies [37], [39] cephalometric magnification was not declared or
retrieved (even though linear measurement used herein were not reported in those investiga-
tions, the rest of the data were set at 0% magnification). Moreover, similar skeletal outcomes
were defined slight differently at the cephalometric recording (see above and Table 11). Finally,
an analysis of the potential responsiveness to treatment according to gender or other prognos-
tic factors was not feasible, and this review has focused on short-term effects.
The GRADE quality of evidence assessment was moderate for several main outcomes
(Table 13) mainly due to the large effect assigned to these outcomes according to the re-establish-
ment of normal growth in Class II patients [32]. However, studies with an improved level of qual-
ity are necessary, with regard to prospective enrolment, full description of Class II features,
Skeletal Maturation and Class II Treatment
PLOS ONE | DOI:10.1371/journal.pone.0141198 October 28, 2015 31 / 35
adequate statistical analysis, and other related information. Even RCTs should rely on skeletal
assessment of Class II malocclusion instead of using the overjet, which is more indicative of promi-
nent upper frontal teeth and not always associated with a genuine Class II skeletal pattern [21].
Clinical implications
Within the limitations and heterogeneity of the included studies it appears that, in spite of the
specific type of appliance used and the protocol followed, functional treatment with removable
appliances would be valid in correcting skeletal Class II malocclusion. However, the effects
behind the correction would be related to treatment timing. Skeletal corrections, including
mainly mandibular elongation with minimal or no maxillary growth restrain, may be achieved if
treatment is performed during the pubertal rather than pre-pubertal growth phase. All the radio-
graphical methods used in the included studies both based on the HWM [33], [37], [39], [41],
[43], [44] and CVMmethod [34–36], [38], [40], [42] methods that have been shown to be related
to the mandibular growth spurt and stature height [48], [49], [50]. Moreover, the CVMmethod
has showed to be repeatable to a satisfactorily level when executed by trained operators [51].
Finally, a simplified third finger maturation (derived from full HWM) and CVMmethods have
showed a good degree of correlation and diagnostic agreement, suggesting a combined use
according to the available radiographical record [52]. This would be particularly useful when
skeletal maturations has to be followed longitudinally in pre-pubertal patients until the beginning
of the pubertal growth phase. However, a pure skeletal effect would not be expected even during
puberty, as some dentoalveolar effects are also present, even though, mandibular incisor procli-
nation consequent to functional treatment would be limited with minimal clinical implications,
especially for pubertal patients. Similarly, an increase of facial divergence was very minimal or
absent in both pre-pubertal and pubertal patients. Even though further evidence is needed, the
use of a reliable indicator of skeletal maturity either HWM or CVMmay be recommended in
routine clinical practice to make efforts to perform treatment during the pubertal growth phase.
Conclusions
Taking into account the still limited quality of the reported studies, and their heterogeneity in
terms of study designs, treatment protocols and appliances used, the following conclusion may
be drawn:
• Functional treatment by removable appliances may be effective in correcting Class II maloc-
clusion with relevant skeletal effects if performed during the pubertal growth phase. Skeletal
effects of functional treatment were seen at the mandibular level and consist mainly in man-
dibular elongation and increase in ramus height, although dentoalveolar effects were detected
even in pubertal patients.
• However, both the increases in total mandibular length and in ramus height showed a note-
worthy individual variation to treatment responsiveness in pubertal patients.
• Irrespective of the growth phase, no or very minimal effects were seen in terms of maxillary
growth restrain or increase in facial divergence
• Further high quality RCTs with proper inclusion criteria for skeletal Class II malocclusion
are needed to fully elucidate the role of growth phase in the efficiency of functional treatment
with removable appliances
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